Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
2,403
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Orexin A ameliorates HBV X protein-induced cytotoxicity and inflammatory response in human hepatocytes

Li WangDepartment of Hepatopancreatobiliary Surgery, He’nan Tumor Hospital, Affiliated to Zhengzhou University, Zhengzhou, ChinaView further author information
,
Tao HeDepartment of Hepatopancreatobiliary Surgery, He’nan Tumor Hospital, Affiliated to Zhengzhou University, Zhengzhou, ChinaView further author information
,
Baishun WanDepartment of Hepatopancreatobiliary Surgery, He’nan Tumor Hospital, Affiliated to Zhengzhou University, Zhengzhou, ChinaView further author information
,
Xiaoqian WangDepartment of Hepatopancreatobiliary Surgery, He’nan Tumor Hospital, Affiliated to Zhengzhou University, Zhengzhou, ChinaView further author information
&
Ling ZhangDepartment of Hepatopancreatobiliary Surgery, He’nan Tumor Hospital, Affiliated to Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
View further author information
Pages 2003-2009 | Received 26 Jan 2019, Accepted 25 Apr 2019, Published online: 20 May 2019

References

  • MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5:a021410
  • Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49:S13–S21.
  • Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261–283.
  • Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479–480:672–686.
  • Carrive P. Orexin, orexin receptor antagonists and central cardiovascular control. Front Neurosci. 2013;7:257.
  • Xu TR, Yang Y, Ward R, et al. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cell Signal. 2013;25:2413–2423.
  • Ebrahim IO, Howard RS, Kopelman MD, et al. The hypocretin/orexin system. J Royal Soc Med. 2002;95:227–230.
  • Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol. 2014;171:294–313.
  • Ju SJ, Zhao Y, Chang X, et al. Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R/PI3K/AKT signaling pathway in hepatocytes. Int J Mol Med. 2014;34:153–159.
  • Zhang C, Sun C, Wang B, et al. Orexin-A stimulates the expression of GLUT4 in a glucose dependent manner in the liver of orange-spotted grouper (Epinephelus coioides). Comp Biochem Physiol A Mol Integr Physiol. 2016;199:95–104.
  • Voisin TE, Firar A, Fasseu M, Rouyer-Fessard C, et al. Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis. Cancer Res. 2011;71:3341–3351.
  • Liu Y, Zhao Y, Guo L. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism. Mol Cell Endocrinol. 2016;420:208–216.
  • Tsuneki H, Tokai E, Nakamura Y, et al. Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice. Diabetes. 2015;64:459–470.
  • Mochizuki A, Nakayama K, Nakamura S, et al. Involvement of orexin in lipid accumulation in the liver. J Oral Biosci. 2018;60:76–82.
  • Ivanov AV, Valuev-Elliston VT, Tyurina DA, et al. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8:3895–3932.
  • Marquez-Quiñones A, Cipak A, Zarkovic K, et al. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res. 2010;44:119–127.
  • Liang S, Kisseleva T, Brenner DA. The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts. Front Physiol. 2016;27:17
  • Berry MN, Edwards AM. The hepatocyte review. Dordrecht: Kulwer Academic Publishers; 2000.
  • Lim W, Kwon SH, Cho H, et al. HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression. J Mol Med. 2010;88:359–369.
  • Papa S, Bubici C, Zazzeroni F, et al. Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem. 2009;390:965–976.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.